Loryn Phillips will graduate from CNM in May with her associate's degree in biotechnology. She plans to go on to get her bachelor's degree in physiology and biochemistry, then her doctorate in molecular biology. After all that school, she hopes to cure cancer....
KOB.COM
READ MORE
|
The pin mold fungus Phycomyces blakesleeanus forms a dense forest of vertically growing fruiting bodies, but how does it know which way is "up"? New research publishing 24 April in the open access journal PLOS Biology, from Gregory Jedd's group at the Temasek Life Sciences Laboratory, National University of Singapore, reveals that the fungi have acquired and re-modelled a gene from bacteria to help them make large gravity-sensing crystals. It was already known that the fruiting bod...
PHYS.ORG
READ MORE
|
Nanotechnology is referred as the manipulation of matter on the super-molecular, molecular, and atomic scale. The earliest description of nanotechnology is the goal of technologically manipulating the molecules and atoms for the fabrication of macro-scale components, commonly known as molecular nanotechnology. Moving to nano-biotechnology, it refers to the miniaturization of biotechnology and the ways in which nanotechnology can be used for the development of devices employed for studying biolog...
OPENPR.
READ MORE
|
Ovarian cancer is not the most common form of cancer, but it's among the deadliest. That's because about 70 percent of cases recur. A new study by researchers at the University of Pittsburgh, UPMC Hillman Cancer Center, Magee-Womens Research Institute (MWRI) and several other collaborating institutions target the root of recurrence with new drugs aimed at annihilating stem-like ovarian cancer cells. The study, published today in the journal Cell Reports, identifies a new experimental dru...
READ MORE
|
Genprex Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intrav...
GENPREX, INC.
READ MORE
|
The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside Ventures, the Series B round will finance a phase IIb trial of Inotrem’s lead candidate drug nangibotide, expected to start in November this year. The company will also use part of the funds to develop a diagnostic tool that can identify those patients most likely to benefit from the treatment...
READ MORE
|